KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Receivables (2017 - 2025)

Amneal Pharmaceuticals has reported Change in Receivables over the past 9 years, most recently at $10.3 million for Q4 2025.

  • Quarterly results put Change in Receivables at $10.3 million for Q4 2025, down 63.86% from a year ago — trailing twelve months through Dec 2025 was $120.6 million (down 25.87% YoY), and the annual figure for FY2025 was $120.6 million, down 25.87%.
  • Change in Receivables for Q4 2025 was $10.3 million at Amneal Pharmaceuticals, down from $77.6 million in the prior quarter.
  • Over the last five years, Change in Receivables for AMRX hit a ceiling of $150.8 million in Q2 2022 and a floor of -$196.0 million in Q1 2023.
  • Median Change in Receivables over the past 5 years was $17.9 million (2023), compared with a mean of $8.6 million.
  • Biggest five-year swings in Change in Receivables: skyrocketed 591.4% in 2022 and later tumbled 323.41% in 2023.
  • Amneal Pharmaceuticals' Change in Receivables stood at $5.0 million in 2021, then skyrocketed by 591.4% to $34.6 million in 2022, then plummeted by 323.41% to -$77.2 million in 2023, then soared by 137.04% to $28.6 million in 2024, then tumbled by 63.86% to $10.3 million in 2025.
  • The last three reported values for Change in Receivables were $10.3 million (Q4 2025), $77.6 million (Q3 2025), and $53.8 million (Q2 2025) per Business Quant data.